quant Healthcare Fund Direct Growth

Fund Overview

Fund Size

₹425 Cr

Expense Ratio

1.49%

ISIN

INF966L01CD0

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

18 Jul 2023

About this fund

quant Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Quant Mutual Fund. This fund has been in existence for 3 years, 3 months and 1 days, having been launched on 18-Jul-23.
As of 16-Oct-26, it has a Net Asset Value (NAV) of ₹18.15, Assets Under Management (AUM) of 424.53 Crores, and an expense ratio of 1.49%.

quant Healthcare Fund Direct Growth has given a CAGR return of 20.14% since inception.
The fund's asset allocation comprises around 99.41% in equities, 0.00% in debts, and 0.59% in cash & cash equivalents.
You can start investing in quant Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+12.02%

+9.65% (Cat Avg.)

3 Years

+18.88%

+19.23% (Cat Avg.)

Since Inception

+20.14%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2026

Equity	₹422.05 Cr	99.41%
Others	₹2.49 Cr	0.59%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Nca-Net Current Assets	Cash	₹-137.12 Cr	32.30%
Treps 01-Oct-2026 Depo 10	Cash - Repurchase Agreement	₹112.81 Cr	26.57%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹41.14 Cr	9.69%
Divi's Laboratories Ltd.	Equity - Future	₹40.89 Cr	9.63%
Zydus Lifesciences Ltd	Equity	₹39.85 Cr	9.39%
Glenmark Pharmaceuticals Ltd.	Equity - Future	₹39.64 Cr	9.34%
Strides Pharma Science Ltd	Equity	₹38.36 Cr	9.04%
Torrent Pharmaceuticals Ltd.	Equity - Future	₹36.6 Cr	8.62%
Pfizer Ltd	Equity	₹31.28 Cr	7.37%
Alivus Life Sciences Ltd	Equity	₹26.38 Cr	6.21%
Ipca Laboratories Ltd	Equity	₹25.39 Cr	5.98%
Aurobindo Pharma Ltd	Equity	₹21.6 Cr	5.09%
Zydus Wellness Ltd	Equity	₹20.79 Cr	4.90%
Aurobindo Pharma Ltd.	Equity - Future	₹19.18 Cr	4.52%
Colgate-Palmolive (India) Ltd	Equity	₹14.64 Cr	3.45%
Natco Pharma Ltd	Equity	₹12.78 Cr	3.01%
Dr Reddy's Laboratories Ltd	Equity	₹9.9 Cr	2.33%
India (Republic of)	Bond - Short-term Government Bills	₹2.99 Cr	0.71%
India (Republic of)	Bond - Short-term Government Bills	₹2.99 Cr	0.70%
India (Republic of)	Bond - Short-term Government Bills	₹2.98 Cr	0.70%
India (Republic of)	Bond - Short-term Government Bills	₹2.98 Cr	0.70%
India (Republic of)	Bond - Short-term Government Bills	₹2.98 Cr	0.70%
India (Republic of)	Bond - Short-term Government Bills	₹2.97 Cr	0.70%
91 Days Treasury Bill 10-Dec-2026	Bond - Gov't/Treasury	₹2.97 Cr	0.70%
91 Days Treasury Bill 17-Dec-2026	Bond - Gov't/Treasury	₹2.97 Cr	0.70%
91 Days Treasury Bill 24-Dec-2026	Bond - Gov't/Treasury	₹2.96 Cr	0.70%
LG Electronics India Ltd	Equity	₹2.52 Cr	0.59%
Sumitomo Chemical India Ltd Ordinary Shares	Equity	₹1.11 Cr	0.26%

Allocation By Market Cap (Equity)

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹246.68 Cr	58.11%
Consumer Defensive	₹35.43 Cr	8.35%
Technology	₹2.52 Cr	0.59%
Basic Materials	₹1.11 Cr	0.26%

Risk & Performance Ratios

Fund Managers

Sanjeev Sharma

Since July 2023

Ankit A. Pande

Since July 2023

Sandeep Tandon

Since July 2023

Varun Pattani

Since January 2025

Sameer Kate

Since March 2025

Ayusha Kumbhat

Since February 2025

Yug Tibrewal

Since March 2025

Additional Scheme Detailsas of 30th September 2026

ISIN

INF966L01CD0

Expense Ratio

1.49%

Exit Load

1.00%

Fund Size

₹425 Cr

Age

3 years 3 months

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

Nifty Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty Pharma ETF Very High Risk	-	-	-	-
Invesco India Pharma and Healthcare Fund Regular Growth Very High Risk	-	0.0%	₹435.52 Cr	-
Invesco India Pharma and Healthcare Fund Direct Growth Very High Risk	-	0.0%	₹435.52 Cr	-
DSP Nifty Healthcare ETF Very High Risk	0.3%	-	₹17.06 Cr	6.6%
Groww BSE Hospitals ETF Very High Risk	0.5%	-	₹159.92 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.3%	-	₹15.36 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	1.2%	0.0%	₹326.54 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹326.54 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	1.2%	1.0%	₹487.35 Cr	5.8%
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.3%	1.0%	₹487.35 Cr	4.1%
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.6%	1.0%	₹405.14 Cr	12.2%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹405.14 Cr	14.1%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹130.33 Cr	15.2%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹130.33 Cr	13.2%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.8%	0.0%	₹926.55 Cr	12.9%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	0.0%	₹926.55 Cr	14.9%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹14.94 Cr	11.4%
Kotak Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹825.14 Cr	20.5%
Kotak Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹825.14 Cr	18.6%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹3501.37 Cr	18.6%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹3501.37 Cr	19.9%
Nippon India Pharma Fund Direct Growth Very High Risk	1.0%	1.0%	₹9166.40 Cr	5.6%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	2.1%	1.0%	₹6861.20 Cr	2.1%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.3%	1.0%	₹6861.20 Cr	2.9%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹3750.04 Cr	12.6%
DSP Healthcare Fund Regular Growth Very High Risk	2.0%	0.0%	₹3750.04 Cr	11.1%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹99.36 Cr	7.4%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.7%	1.0%	₹99.36 Cr	6.0%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹424.53 Cr	12.0%
quant Healthcare Fund Regular Growth Very High Risk	3.1%	1.0%	₹424.53 Cr	10.2%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1429.84 Cr	10.2%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	1.0%	0.0%	₹5870.00 Cr	12.7%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	0.0%	₹1511.49 Cr	1.4%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	0.0%	₹1511.49 Cr	2.8%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.2%	-	₹231.43 Cr	6.6%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	2.0%	0.0%	₹5870.00 Cr	11.6%
Nippon India Pharma Fund Regular Growth Very High Risk	1.8%	1.0%	₹9166.40 Cr	4.7%
UTI Healthcare Fund Regular Growth Very High Risk	2.2%	1.0%	₹1429.84 Cr	9.2%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹23.07 Cr	6.4%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1736.44 Cr	17.1%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	2.0%	1.0%	₹3494.44 Cr	12.3%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.6%	1.0%	₹3494.44 Cr	13.9%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹266.05 Cr	3.7%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹266.05 Cr	5.6%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹74.67 Cr	6.6%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1077.52 Cr	9.2%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹1077.52 Cr	10.6%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.4%	-	₹44.40 Cr	8.4%

About the AMC

Quant Mutual Fund

022-62955000

https://quantmutual.com/

Total AUM

₹1,06,621 Cr

Address

A.M. Road, Prabhadevi, Mumbai, 400025

Other Funds by Quant Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Quant Nifty Midcap 150 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 100 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 50 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
quant Income Plus Arbitrage Active FOF Direct Growth Moderate Risk	-	0.0%	₹54.94 Cr	-
qsif Sector Rotation Long-Short Fund Direct Growth Very High Risk	2.8%	1.0%	₹48.58 Cr	-
qsif Active Asset Allocator Long-Short Fund Regular Growth Moderately High risk	2.4%	1.0%	₹167.45 Cr	-
qsif Equity Ex-Top 100 Long-Short Fund Direct Growth Moderately High risk	2.8%	1.0%	₹419.99 Cr	-
qsif Hybrid Long-Short Fund Direct Growth Very High Risk	2.1%	0.0%	₹213.71 Cr	-
qsif Equity Long-Short Fund Direct Growth High Risk	3.1%	1.0%	₹758.21 Cr	9.9%
quant Equity Savings Fund Direct Growth Moderate Risk	2.0%	1.0%	₹59.84 Cr	7.3%
Quant Arbitrage Fund Direct Growth Low Risk	1.7%	0.0%	₹1007.10 Cr	7.6%
Quant PSU Fund Direct Growth Very High Risk	2.2%	1.0%	₹400.44 Cr	-0.7%
Quant Consumption Fund Direct Growth Very High Risk	1.7%	1.0%	₹179.65 Cr	0.1%
Quant Commodities Fund Direct Growth Very High Risk	1.8%	1.0%	₹335.23 Cr	6.6%
Quant Momentum Fund Direct Growth Very High Risk	1.9%	1.0%	₹1269.07 Cr	6.0%
Quant Teck Fund Direct Growth Very High Risk	2.3%	1.0%	₹243.12 Cr	-3.9%
Quant Value Fund Direct Growth Very High Risk	0.9%	1.0%	₹1917.40 Cr	10.2%
Quant BFSI Fund Direct Growth Very High Risk	1.9%	1.0%	₹893.84 Cr	8.2%
quant Healthcare Fund Direct Growth Very High Risk	1.5%	1.0%	₹424.53 Cr	12.0%
Quant Quantamental Fund Direct Growth Very High Risk	1.6%	1.0%	₹1546.75 Cr	4.9%
Tata Quant Fund Direct Growth Very High Risk	0.9%	1.0%	₹61.70 Cr	8.5%
Quant Focused fund Direct Growth Very High Risk	1.9%	1.0%	₹824.66 Cr	5.4%
Quant Large and Mid Cap Fund Direct Growth Very High Risk	1.3%	1.0%	₹3384.49 Cr	7.1%
Quant Active Fund Direct Growth Very High Risk	1.0%	1.0%	₹7501.45 Cr	3.7%
Quant Small Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹35572.02 Cr	11.1%
Quant Absolute Fund Direct Growth Very High Risk	1.4%	1.0%	₹2107.64 Cr	3.8%
Quant Infrastructure Fund Direct Growth Very High Risk	1.1%	0.0%	₹3076.40 Cr	6.2%
Quant Multi Asset Fund Direct Growth High Risk	1.1%	1.0%	₹6608.27 Cr	10.5%
Quant Flexi Cap Fund Direct Growth Very High Risk	1.1%	1.0%	₹7309.35 Cr	5.7%
Quant Tax Plan Direct Growth Very High Risk	1.2%	0.0%	₹13103.36 Cr	6.6%
Quant Liquid Plan Direct Growth Low to Moderate Risk	0.3%	0.0%	₹1148.99 Cr	6.1%
Quant Mid Cap Fund Direct Growth Very High Risk	1.2%	0.0%	₹7653.83 Cr	0.9%
Quant Gilt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹73.11 Cr	1.7%
Quant Manufacturing Fund Direct Growth Very High Risk	1.5%	1.0%	₹712.69 Cr	8.1%
Quant Business Cycle Fund Direct Growth Very High Risk	1.4%	1.0%	₹929.90 Cr	2.6%
Quant ESG Equity Fund Direct Growth Very High Risk	1.9%	1.0%	₹327.87 Cr	17.7%
Quant Overnight Fund Direct Growth Low Risk	0.2%	0.0%	₹53.70 Cr	5.0%
Quant Large Cap Fund Direct Growth Very High Risk	1.5%	1.0%	₹3668.60 Cr	1.5%
Quant Dynamic Asset Allocation Fund Direct Growth Very High Risk	1.6%	1.0%	₹810.16 Cr	-2.9%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of quant Healthcare Fund Direct Growth?

The NAV of quant Healthcare Fund Direct Growth, as of 16-Oct-2026, is ₹18.15.

What are the returns of quant Healthcare Fund Direct Growth?

The fund has generated 12.02% over the last 1 year and 18.88% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of quant Healthcare Fund Direct Growth?

The fund's allocation of assets is distributed as 99.41% in equities, 0.00% in bonds, and 0.59% in cash and cash equivalents.

Who manages the quant Healthcare Fund Direct Growth?

The fund managers responsible for quant Healthcare Fund Direct Growth are:-

Sanjeev Sharma
Ankit A. Pande
Sandeep Tandon
Varun Pattani
Sameer Kate
Ayusha Kumbhat
Yug Tibrewal

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

quant Healthcare Fund Direct Growth

Fund Overview